Stock listing

NASDAQ:NVCR NovoCure Limited Stock

Home listing (NASDAQ) of NovoCure Limited

Follow NovoCure Limited into a list and get an email when it puts out news.

Share price · NASDAQ:NVCR

$10.71 USD -0.02 (-0.2%)

Close on Nov 20, 2026

Past year -6.5% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$10.61 – $11.06 USDNov 20, 2026
Volume
1.64M sharesNov 20, 2026
Market cap
$1.25B USDAt the close on Nov 20, 2026 · price × 116.4M shares outstanding
52-week range
$9.82 – $21.45 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$21.77M USDMedian day 1.29M shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
NovoCure Limited logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:NVCR · Home$10.71 USD-0.02 (-0.2%)1,639,199$10.61$11.06$10.61$10.73Close on Nov 20, 2026
Frankfurt:038€9.70 EUR+0.134 (+1.4%)—€9.406€9.70€9.406€9.566Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:NVCR · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$10.71-0.02-0.2%$10.61$11.06$10.611,639,199
$10.73-0.41-3.7%$11.16$11.35$10.691,409,845
$11.14-0.16-1.4%$11.31$11.51$11.051,442,838
$11.30-0.53-4.5%$11.61$11.72$11.252,438,113
$11.83+0.11+0.9%$11.70$11.88$11.441,051,730
$11.72-0.27-2.3%$11.84$12.11$11.631,246,669
$11.99+0.18+1.5%$12.01$12.41$11.751,533,011
$11.81-0.72-5.7%$12.68$12.95$11.561,928,993
$12.53-0.75-5.6%$12.99$13.23$12.252,379,205
$13.28-0.27-2.0%$13.52$13.59$13.061,143,981
$13.55-1.06-7.3%$14.61$14.68$13.491,695,043
$14.61+1.18+8.8%$14.00$14.94$13.921,647,780
$13.43+0.22+1.7%$13.30$13.56$13.211,652,338
$13.21+0.06+0.5%$13.33$13.67$13.091,647,264
$13.15+0.04+0.3%$12.81$13.26$12.531,974,507
$13.11-1.06-7.5%$12.90$13.85$11.855,953,164
$14.17-0.45-3.1%$14.42$14.64$13.852,383,079
$14.62+0.22+1.5%$14.40$14.74$14.112,147,157
$14.40-0.28-1.9%$14.47$14.90$14.201,166,269
$14.68-0.42-2.8%$14.85$14.97$14.531,125,100
$15.10-0.49-3.1%$15.55$15.66$14.941,059,800
$15.59-0.12-0.8%$15.60$16.09$15.432,599,200
$15.71+0.82+5.5%$14.98$15.82$14.911,737,800
$14.89+0.82+5.8%$14.14$15.00$14.142,225,000
$14.07-0.34-2.4%$14.41$14.41$13.881,287,600
$14.41+0.57+4.1%$13.85$14.46$13.841,810,600
$13.84-0.46-3.2%$14.15$14.26$13.761,186,000
$14.30-0.42-2.9%$14.66$14.75$14.29772,600
$14.72+0.14+1.0%$14.54$14.76$14.26782,000
$14.58+0.36+2.5%$14.17$14.78$14.141,022,300
$14.22-0.44-3.0%$14.59$14.59$13.822,956,800
$14.66-0.31-2.1%$14.84$15.12$14.593,513,300
$14.97-0.23-1.5%$15.27$15.88$14.901,763,300
$15.20+0.26+1.7%$14.83$15.30$14.561,784,600
$14.94-0.98-6.2%$16.24$16.24$14.921,695,100
$15.92-0.03-0.2%$15.81$16.44$15.771,208,100
$15.95-0.04-0.3%$16.01$16.10$15.731,876,600
$15.99+0.16+1.0%$15.87$16.07$15.64728,500
$15.83-0.01-0.1%$15.68$15.90$15.20896,000
$15.84-0.36-2.2%$16.20$16.27$15.821,028,000
$16.20-0.05-0.3%$16.43$16.43$15.731,142,600
$16.25-0.42-2.5%$16.53$16.75$15.97777,700
$16.67+0.14+0.8%$16.70$16.79$16.541,044,600
$16.53-0.16-1.0%$16.87$16.87$16.37633,500
$16.69-0.03-0.2%$16.70$16.87$16.531,152,700
$16.72+0.50+3.1%$16.58$16.99$16.131,482,600
$16.22+0.07+0.4%$16.18$16.55$16.011,639,300
$16.15-0.07-0.4%$16.13$16.66$15.96914,800
$16.22+0.71+4.6%$15.49$16.25$15.291,049,300
$15.51+0.16+1.0%$15.50$16.00$15.351,127,200
$15.35-0.28-1.8%$15.26$16.07$15.101,385,200
$15.63-1.22-7.2%$16.56$16.65$15.60995,500
$16.85-1.09-6.1%$17.64$17.78$16.571,459,700
$17.94+0.30+1.7%$17.53$18.02$17.47732,000
$17.64-0.19-1.1%$17.94$18.05$17.42613,400
$17.83+0.45+2.6%$17.88$18.59$17.501,324,000
$17.38-0.27-1.5%$17.36$17.88$17.29800,300
$17.65-0.17-1.0%$17.55$17.97$17.39914,800
$17.82-0.17-0.9%$17.99$18.16$17.42855,600
$17.99+0.10+0.6%$17.92$18.21$17.48763,400
$17.89+0.27+1.5%$17.43$17.97$17.151,270,900
$17.62+0.86+5.1%$16.98$17.64$16.92902,900
$16.76-0.34-2.0%$17.02$17.06$16.331,607,200
$17.10-0.67-3.8%$17.75$17.83$17.011,403,800
$17.77-0.43-2.4%$18.12$18.61$17.48955,700
Ticker
NASDAQ:NVCR
Asset type
Stock
Sector
Health care
Industry
Medical devices & supplies
Exchange
NASDAQ
Currency
USD

What changed lately

Latest news

All NovoCure Limited news

NovoCure Limited on 6ix

Sector
Health care
Industry
Medical devices & supplies
News releases
23 in the last 12 months · 192 in all · newest Nov 19, 2026 · oldest 2020
Calls
25 calls with a replay · 25 with a transcript · latest Oct 29, 2026
Decks
42 decks · latest Oct 29, 2026

Where NovoCure Limited is listed

ListingExchangeCountryCurrency
NASDAQ:NVCR · Home listing · This pageNASDAQUnited StatesUSD
gettex:038gettexGermanyEUR
LS Exchange:A140MLLS ExchangeGermanyEUR
BOATS:NVCRBOATSUnited StatesUSD
Lang & Schwarz:A140MLLang & SchwarzGermanyEUR
B3:N2VC34B3BrazilBRL
Tradegate:038TradegateGermanyEUR
BMV:NVCRNBMVMexicoMXN
BIVA:NVCRNBIVAMexicoMXN
Frankfurt:038FrankfurtGermanyEUR
Dusseldorf:038DusseldorfGermanyEUR
Munich:038MunichGermanyEUR
Stuttgart:038StuttgartGermanyEUR
BSESOF:038BSESOFBulgariaEUR

Valuation

EV/sales 1.6× against a median of 3.4×: 4th lowest of 11 Medical devices & supplies companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
$1.18B USD
P/E
Loss
EV/sales
1.6×
EV/EBITDA
Negative EBITDA
Price/book
3.6×
Gross margin
77.0%
Operating margin
−17.2%
Net margin
−16.8%
Debt to equity
0.1×
Beta vs S&P 500
1.31

Medical devices & supplies: the 10 companies nearest in size, of 448 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
NovoCure Limited · NASDAQ:NVCRUS$1.25BUS$1.18Bn/a1.6×n/a3.6×−16.8%0.1×1.31
PROCEPT BioRobotics Corporation · NASDAQ:PRCTUS$1.42BUS$1.25Bn/a3.6×n/a4.3×−32.6%0.2×0.89
CONMED Corporation · NYSE:CNMDUS$1.39BUS$2.16B29.6×1.6×18.1×1.3×3.4%0.8×0.77
Cofoe Medical Technology Co., Ltd. Class A · SZSE:301087US$1.36BUS$930.0M21.9×1.5×n/a1.7×10.0%0.0×n/a
Butterfly Network, Inc. · NYSE:BFLYUS$1.33BUS$1.21Bn/a9.8×n/a7.2×−43.6%0.0×2.86
Beijing Balance Medical Technology Co. Ltd. Class A · SSE:688198US$1.27BUS$1.26B47.8×12.8×n/a7.2×27.2%0.1×n/a
Shanghai MicroPort EP Medtech Co., Ltd. Class A · SSE:688351US$1.24BUS$1.05B144×12.8×n/a4.5×10.4%0.0×n/a
Sonoscape Medical Corp. Class A · SZSE:300633US$1.23BUS$1.11B47.0×3.0×n/a2.7×7.2%0.1×n/a
Tandem Diabetes Care, Inc. · NASDAQ:TNDMUS$1.22BUS$1.38Bn/a1.3×n/a9.0×−4.6%4.5×0.97
STAAR Surgical Company · NASDAQ:STAAUS$1.22BUS$1.04B2,294×3.2×120×3.2×0.2%0.1×0.45
Eyebright Medical Technology (Beijing) Co., Ltd. Class A · SSE:688050US$1.18BUS$1.21B32.6×4.5×n/a2.6×13.5%0.3×n/a
Median of the othersUS$1.26BUS$1.21B47.0×3.4×69.2×3.8×5.3%0.1×0.89

Forecasts

3 strong buy · 1 buy · 3 hold · Analysts' consensus from EODHD, read Nov 20, 2026. Not 6ix's view and not investment advice.

Price target
26.14 USD · Analysts' mean
EPS, year to Dec 2026
-1.05 · 6 analysts
Revenue, year to Dec 2026
740.2M · 6 analysts

Team and board

Officers

OfficerRole
Frank LeonardChief Executive Officer
Christoph BrackmannChief Financial Officer
Mukund ParavasthuChief Operating Officer
Michael PuriChief Human Resources Officer
Uri WeinbergChief Medical & Innovation Officer
William F. DoyleExecutive Chairman

Board

DirectorRole
William F. DoyleExecutive Chairman
Allyson J. Ocean
Asaf Danziger
David T. Hung
Jeryl Hilleman
Kinyip Gabriel Leung
Kristin Stafford
Martin J. Madden
William A. Vernon

Events

Calls

CallWhenStatus
NovoCure (NASDAQ:NVCR) Q3 2026 Earnings CallThu, Oct 29, 2026 · 8:00 AM ETReplay
NovoCure (NASDAQ:NVCR) Q2 2026 Earnings CallThu, Jul 23, 2026 · 8:00 AM ETReplay
NovoCure (NASDAQ:NVCR) Q1 2026 Earnings CallThu, Apr 30, 2026 · 8:00 AM ETReplay
NovoCure (NASDAQ:NVCR) Q4 2025 Earnings CallThu, Feb 26, 2026 · 8:00 AM ETReplay
NovoCure (NASDAQ:NVCR) Q3 2025 Earnings CallThu, Oct 30, 2025 · 8:00 AM ETReplay
NovoCure (NASDAQ:NVCR) Q2 2025 Earnings CallThu, Jul 24, 2025 · 8:00 AM ETReplay
NovoCure (NASDAQ:NVCR) Q1 2025 Earnings CallThu, Apr 24, 2025 · 8:00 AM ETReplay
NovoCure (NASDAQ:NVCR) Q4 2024 Earnings CallThu, Feb 27, 2025 · 8:00 AM ETReplay
NovoCure (NASDAQ:NVCR) Q3 2024 Earnings CallWed, Oct 30, 2024 · 8:00 AM ETReplay
NovoCure (NASDAQ:NVCR) Q2 2024 Earnings CallThu, Jul 25, 2024 · 8:00 AM ETReplay
All 25 calls
CallWhenStatus
NovoCure (NASDAQ:NVCR) Q1 2024 Earnings CallThu, May 02, 2024 · 8:00 AM ETReplay
NovoCure (NASDAQ:NVCR) Q4 2023 Earnings CallThu, Feb 22, 2024 · 8:00 AM ETReplay
NovoCure (NASDAQ:NVCR) Q3 2023 Earnings CallThu, Oct 26, 2023 · 8:00 AM ETReplay
NovoCure (NASDAQ:NVCR) Q2 2023 Earnings CallThu, Jul 27, 2023 · 8:00 AM ETReplay
NovoCure (NASDAQ:NVCR) Q1 2023 Earnings CallThu, May 04, 2023 · 8:00 AM ETReplay
NovoCure (NASDAQ:NVCR) Q4 2022 Earnings CallThu, Feb 23, 2023 · 8:00 AM ETReplay
NovoCure (NASDAQ:NVCR) Q3 2022 Earnings CallThu, Oct 27, 2022 · 8:00 AM ETReplay
NovoCure (NASDAQ:NVCR) Q2 2022 Earnings CallThu, Jul 28, 2022 · 8:00 AM ETReplay
NovoCure (NASDAQ:NVCR) Q1 2022 Earnings CallThu, Apr 28, 2022 · 8:00 AM ETReplay
NovoCure (NASDAQ:NVCR) Q4 2021 Earnings CallThu, Feb 24, 2022 · 8:00 AM ETReplay
NovoCure (NASDAQ:NVCR) Q3 2021 Earnings CallThu, Oct 28, 2021 · 8:00 AM ETReplay
NovoCure (NASDAQ:NVCR) Q2 2021 Earnings CallThu, Jul 29, 2021 · 8:00 AM ETReplay
NovoCure (NASDAQ:NVCR) Q1 2021 Earnings CallThu, Apr 29, 2021 · 8:00 AM ETReplay
NovoCure (NASDAQ:NVCR) Q4 2020 Earnings CallTue, Jan 12, 2021 · 8:30 AM ETReplay
NovoCure (NASDAQ:NVCR) Q3 2020 Earnings CallThu, Oct 29, 2020 · 8:00 AM ETReplay

Results days

QuarterResultsShare move
Q3 2026Oct 29, 2026 · Before open−7.5%
Q2 2026Jul 23, 2026 · Before open+28.4%
Q1 2026Apr 30, 2026 · Before open+27.5%
Q4 2025Feb 26, 2026−8.8%
Q3 2025Oct 30, 2025 · Before open−4.9%
Q2 2025Jul 24, 2025 · Before open−24.1%
Q1 2025Apr 24, 2025 · Before open+4.4%
Q4 2024Feb 27, 2025−13.2%
Q3 2024Oct 30, 2024 · Before open+0.6%
Q2 2024Jul 25, 2024 · Before open−0.8%
All 20 quarters
QuarterResultsShare move
Q1 2024May 2, 2024 · Before open+11.4%
Q4 2023Feb 22, 2024 · Before open−2.4%
Q3 2023Oct 26, 2023 · Before open−7.5%
Q2 2023Jul 27, 2023 · Before open−15.9%
Q1 2023May 4, 2023 · Before open+1.2%
Q4 2022Feb 23, 2023 · Before open−4.5%
Q3 2022Oct 27, 2022 · Before open+0.2%
Q2 2022Jul 28, 2022 · Before open−5.0%
Q1 2022Apr 28, 2022 · Before open+0.3%
Q4 2021Feb 24, 2022 · Before open+6.8%

Open Events

Decks

DeckKindSlidesDate
Q3 2026 Earnings PresentationEarnings15 slidesOct 29, 2026
Q2 2026 Earnings PresentationEarnings12 slidesJul 23, 2026
Investor Presentation (July 2026)Investor deck15 slidesJuly 2026
Q1 2026 Earnings PresentationEarnings12 slidesApr 30, 2026
Q4 2025 Earnings PresentationEarnings12 slidesFeb 26, 2026
Q3 2025 Earnings PresentationEarnings11 slidesOct 30, 2025
Q2 2025 Earnings PresentationEarnings13 slidesJul 24, 2025
Technical Presentation (June 2025)Technical26 slidesJun 2, 2025
Investor Day (June 2025)Investor day43 slidesJun 2, 2025
Investor Presentation (October 2024)Investor deck22 slidesOctober 2024
All 42 decks
DeckKindSlidesDate
Investor Presentation (October 2024)Investor deck23 slidesOctober 2024
Investor Presentation (July 2024)Investor deck29 slidesJuly 2024
Investor Presentation (July 2024)Investor deck30 slidesJuly 2024
Q4 2023 Earnings PresentationEarnings14 slidesFebruary 2024
Investor Presentation (February 2024)Investor deck33 slidesFebruary 2024
Investor Presentation (January 2024)Investor deck34 slidesJanuary 2024
Q3 2023 Earnings PresentationEarnings14 slidesOctober 2023
Investor Presentation (October 2023)Investor deck37 slidesOctober 2023
Fact Sheet (September 2023)Fact sheet5 slidesSeptember 2023
Investor Presentation (September 2023)Investor deck37 slidesSeptember 2023
Investor Presentation (August 2023)Investor deck41 slidesAugust 2023
Q2 2023 Earnings PresentationEarnings13 slidesJul 27, 2023
Technical Presentation (June 2023)Technical23 slidesJun 6, 2023
ASCO Investor Event 2023Conference30 slidesJun 6, 2023
Investor Presentation (May 2023)Investor deck39 slidesMay 2023
Fact Sheet (April 2023)Fact sheet4 slidesApril 2023
Investor Presentation (March 2023)Investor deck40 slidesMarch 2023
Q4 2022 Earnings PresentationEarnings16 slidesFeb 23, 2023
Investor Presentation (February 2023)Investor deck40 slidesFebruary 2023
Fact Sheet (January 2023)Fact sheet4 slidesJanuary 2023
Investor Presentation (January 2023)Investor deck23 slidesJanuary 2023
Investor Presentation (October 2022)Investor deck35 slidesOctober 2022
Investor Presentation (July 2022)Investor deck45 slidesJuly 2022
Investor Presentation (April 2022)Investor deck45 slidesApril 2022
Investor Presentation (January 2019)Investor deck52 slidesJanuary 2019
Investor Presentation (May 2017)Investor deck44 slidesMay 2017
Investor Presentation (August 2016)Investor deck44 slidesAug 15, 2016
Investor Presentation (May 2016)Investor deck26 slidesMay 25, 2016
Cowen and Company 36th Annual Health Care Conference (March 2016)Conference20 slidesMar 1, 2016
Investor Presentation (March 2016)Investor deck25 slidesMar 1, 2016
Corporate Update (December 2015)Corporate update17 slidesDec 15, 2015
Fact Sheet (March 2015)Fact sheet1 slideMar 31, 2015

Open Decks

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue655.4M605.2M509.3M537.8M535.0M494.4M351.3M248.1M177.0M82.9M
Cost of revenue166.9M137.2M128.3M114.9M114.9M106.5M88.6M80.0M55.6M39.9M
Gross profit488.5M468.0M381.1M423.0M420.2M387.9M262.7M168.0M121.4M36.6M
Research and development224.5M209.6M223.1M206.1M201.3M132.0M79.0M50.6M38.1M41.5M
Operating income-153.8M-170.5M-232.9M-89.5M-44.3M30.4M-914.0K-33.7M-39.3M-115.3M
Depreciation and amortization14.7M11.2M11.0M10.6M10.3M9.15M8.46M9.01M7.68M5.65M
EBITDA-139.2M-159.3M-221.9M-78.9M-34.1M39.6M7.55M-24.7M-31.7M-109.7M
Interest expense22.2M11.7M4.91M8.11M8.84M18.1M14.6M16.9M11.7M7.32M
Income before tax-136.3M-131.2M-191.7M-81.8M-52.1M18.1M-8.82M-45.9M-48.5M-121.5M
Income tax-23.0K37.5M15.3M10.7M6.28M-1.71M-1.59M17.6M13.2M10.4M
Net income-136.2M-168.6M-207.0M-92.5M-58.4M19.8M-7.23M-63.6M-61.7M-131.8M
Earnings per share, basic-1.22-1.56-1.95-0.88-0.560.20-0.07-0.69-0.70-1.54
Earnings per share, diluted-1.22-1.56-1.95-0.88-0.560.18-0.07-0.69-0.70-1.54

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents93.5M163.8M240.8M115.3M208.8M234.7M177.3M140.6M78.6M99.8M
Receivables89.4M74.2M61.2M86.3M93.6M96.7M58.9M36.5M29.6M6.34M
Inventory41.1M35.1M38.2M29.4M24.4M27.4M23.7M22.6M22.0M25.5M
Current assets646.7M1.11B1.03B1.11B1.07B999.4M439.9M321.4M245.1M261.9M
Property, plant and equipment77.6M77.7M51.5M32.7M22.7M11.4M9.34M8.44M9.03M9.81M
Total assets804.3M1.24B1.15B1.19B1.14B1.05B479.4M339.8M265.3M282.1M
Current liabilities223.2M756.4M179.1M158.8M142.6M113.6M86.3M64.6M50.2M36.9M
Long-term debt195.0M97.3M568.8M565.5M562.2M429.9M149.4M149.3M97.3M96.2M
Total debt195.0M97.3M568.8M565.5M562.2M429.9M149.4M125.0K160.0K263.0K
Total liabilities463.9M880.6M783.6M750.5M729.0M575.5M261.7M227.5M151.7M139.7M
Shareholders' equity340.5M360.2M362.5M441.2M410.5M476.5M217.8M112.3M113.6M142.3M
Shares outstanding112.5M108.5M107.1M105.0M104.0M102.3M99.5M93.3M89.5M87.1M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations-49.0M-26.4M-73.3M30.8M82.8M99.1M26.6M-1.86M-33.1M-107.6M
Capital spending-26.6M-42.9M-27.1M-21.4M-24.2M-15.0M-10.5M-6.71M-7.37M-5.67M
Free cash flow-75.7M-69.2M-100.4M9.43M58.6M84.2M16.1M-8.58M-40.5M-113.3M
Cash from investing437.3M-140.2M184.1M-140.0M-144.8M-472.8M-51.7M-5.49M8.63M13.0M
Cash from financing-451.3M90.3M15.8M15.5M25.7M440.2M61.7M69.4M5.17M75.1M
Dividends paid00
Change in cash-62.7M-76.5M126.7M-93.8M-36.6M66.8M36.7M62.0M-19.3M-19.6M

Open Financials

Filings

FilingDateTypeFiled with
4 · Change in ownershipNov 12, 2026Insider tradeSEC
4 · Change in ownershipNov 12, 2026Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 9, 2026Big-stake noticeSEC
144 · Notice of proposed saleNov 9, 2026Other filingsSEC
8-K · Current reportNov 9, 2026Current reportSEC
4 · Change in ownershipNov 4, 2026Insider tradeSEC
S-8 · Registration statement for employee plansOct 29, 2026Offer documentSEC
8-K · Current reportOct 29, 2026ResultsSEC
10-Q · Quarterly reportOct 29, 2026Quarterly reportSEC
8-K · Current reportOct 1, 2026Current reportSEC
Show 200 filings
FilingDateTypeFiled with
8-K · Current reportSep 9, 2026Management or board changeSEC
8-K · Current reportSep 1, 2026Current reportSEC
144 · Notice of proposed saleJul 23, 2026Other filingsSEC
8-K · Current reportJul 23, 2026ResultsSEC
10-Q · Quarterly reportJul 23, 2026Quarterly reportSEC
4 · Change in ownershipJul 1, 2026Insider tradeSEC
4 · Change in ownershipJul 1, 2026Insider tradeSEC
4 · Change in ownershipJul 1, 2026Insider tradeSEC
4 · Change in ownershipJul 1, 2026Insider tradeSEC
8-K · Current reportJun 30, 2026Current reportSEC
8-K · Current reportJun 18, 2026Current reportSEC
8-K · Current reportJun 5, 2026Management or board changeSEC
4 · Change in ownershipJun 5, 2026Insider tradeSEC
4 · Change in ownershipJun 5, 2026Insider tradeSEC
4 · Change in ownershipJun 5, 2026Insider tradeSEC
4 · Change in ownershipJun 5, 2026Insider tradeSEC
4 · Change in ownershipJun 5, 2026Insider tradeSEC
4 · Change in ownershipJun 5, 2026Insider tradeSEC
4 · Change in ownershipJun 5, 2026Insider tradeSEC
4 · Change in ownershipJun 5, 2026Insider tradeSEC
4 · Change in ownershipJun 5, 2026Insider tradeSEC
144 · Notice of proposed saleJun 4, 2026Other filingsSEC
4 · Change in ownershipJun 3, 2026Insider tradeSEC
4 · Change in ownershipJun 3, 2026Insider tradeSEC
4 · Change in ownershipJun 3, 2026Insider tradeSEC
4 · Change in ownershipJun 3, 2026Insider tradeSEC
4 · Change in ownershipJun 3, 2026Insider tradeSEC
4 · Change in ownershipJun 3, 2026Insider tradeSEC
4 · Change in ownershipJun 3, 2026Insider tradeSEC
DEFA14A · Additional proxy materialMay 21, 2026Meeting noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 8, 2026Big-stake noticeSEC
8-K · Current reportApr 30, 2026ResultsSEC
10-Q · Quarterly reportApr 30, 2026Quarterly reportSEC
4 · Change in ownershipApr 28, 2026Insider tradeSEC
SCHEDULE 13G · Big-stake noticeApr 28, 2026Big-stake noticeSEC
8-K/A · Current report, amendedApr 24, 2026Management or board changeSEC
DEFA14A · Additional proxy materialApr 20, 2026Meeting noticeSEC
DEF 14A · Proxy statementApr 20, 2026Meeting noticeSEC
8-K · Current reportApr 9, 2026Management or board changeSEC
SCHEDULE 13G/A · Big-stake notice, amendedMar 26, 2026Big-stake noticeSEC
8-K · Current reportMar 26, 2026Current reportSEC
4 · Change in ownershipMar 5, 2026Insider tradeSEC
4 · Change in ownershipMar 5, 2026Insider tradeSEC
4 · Change in ownershipMar 5, 2026Insider tradeSEC
4 · Change in ownershipMar 5, 2026Insider tradeSEC
4 · Change in ownershipMar 5, 2026Insider tradeSEC
4 · Change in ownershipMar 5, 2026Insider tradeSEC
4 · Change in ownershipMar 5, 2026Insider tradeSEC
4 · Change in ownershipMar 5, 2026Insider tradeSEC
4 · Change in ownershipMar 5, 2026Insider tradeSEC
144 · Notice of proposed saleMar 5, 2026Other filingsSEC
144 · Notice of proposed saleMar 4, 2026Other filingsSEC
144 · Notice of proposed saleMar 4, 2026Other filingsSEC
144 · Notice of proposed saleMar 4, 2026Other filingsSEC
144 · Notice of proposed saleMar 4, 2026Other filingsSEC
144 · Notice of proposed saleMar 3, 2026Other filingsSEC
4 · Change in ownershipMar 3, 2026Insider tradeSEC
4 · Change in ownershipMar 3, 2026Insider tradeSEC
4 · Change in ownershipMar 3, 2026Insider tradeSEC
4 · Change in ownershipMar 3, 2026Insider tradeSEC
4 · Change in ownershipMar 3, 2026Insider tradeSEC
4 · Change in ownershipMar 3, 2026Insider tradeSEC
4 · Change in ownershipMar 3, 2026Insider tradeSEC
144 · Notice of proposed saleMar 2, 2026Other filingsSEC
144 · Notice of proposed saleMar 2, 2026Other filingsSEC
144 · Notice of proposed saleFeb 27, 2026Other filingsSEC
144 · Notice of proposed saleFeb 27, 2026Other filingsSEC
S-8 · Registration statement for employee plansFeb 26, 2026Offer documentSEC
10-K · Annual reportFeb 26, 2026Annual reportSEC
8-K · Current reportFeb 26, 2026ResultsSEC
8-K · Current reportFeb 24, 2026Current reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 12, 2026Big-stake noticeSEC
8-K · Current reportFeb 11, 2026Current reportSEC
8-K · Current reportFeb 5, 2026Current reportSEC
4 · Change in ownershipJan 12, 2026Insider tradeSEC
8-K · Current reportJan 12, 2026ResultsSEC
5 · Annual statement of ownershipJan 8, 2026Insider tradeSEC
5 · Annual statement of ownershipJan 8, 2026Insider tradeSEC
5 · Annual statement of ownershipJan 8, 2026Insider tradeSEC
8-K · Current reportDec 1, 2025Management or board changeSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 13, 2025Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 7, 2025Big-stake noticeSEC
4 · Change in ownershipNov 4, 2025Insider tradeSEC
4 · Change in ownershipNov 4, 2025Insider tradeSEC
4 · Change in ownershipNov 4, 2025Insider tradeSEC
4 · Change in ownershipNov 4, 2025Insider tradeSEC
10-Q · Quarterly reportOct 30, 2025Quarterly reportSEC
8-K · Current reportOct 30, 2025ResultsSEC
8-K · Current reportSep 15, 2025Current reportSEC
4 · Change in ownershipSep 8, 2025Insider tradeSEC
8-K · Current reportAug 28, 2025Current reportSEC
SCHEDULE 13G · Big-stake noticeAug 13, 2025Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 5, 2025Big-stake noticeSEC
4 · Change in ownershipJul 30, 2025Insider tradeSEC
8-K · Current reportJul 24, 2025ResultsSEC
10-Q · Quarterly reportJul 24, 2025Quarterly reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedJul 7, 2025Big-stake noticeSEC
4 · Change in ownershipJul 1, 2025Insider tradeSEC
4 · Change in ownershipJul 1, 2025Insider tradeSEC
4 · Change in ownershipJul 1, 2025Insider tradeSEC
4 · Change in ownershipJul 1, 2025Insider tradeSEC
4 · Change in ownershipJul 1, 2025Insider tradeSEC
S-8 POSJun 30, 2025Offer documentSEC
S-8 POSJun 30, 2025Offer documentSEC
S-8 POSJun 30, 2025Offer documentSEC
S-8 POSJun 30, 2025Offer documentSEC
S-8 POSJun 30, 2025Offer documentSEC
S-8 POSJun 30, 2025Offer documentSEC
S-8 POSJun 30, 2025Offer documentSEC
8-K · Current reportJun 6, 2025Management or board changeSEC
4 · Change in ownershipJun 6, 2025Insider tradeSEC
4 · Change in ownershipJun 6, 2025Insider tradeSEC
4 · Change in ownershipJun 6, 2025Insider tradeSEC
4 · Change in ownershipJun 6, 2025Insider tradeSEC
4 · Change in ownershipJun 6, 2025Insider tradeSEC
4 · Change in ownershipJun 6, 2025Insider tradeSEC
4 · Change in ownershipJun 6, 2025Insider tradeSEC
4 · Change in ownershipJun 6, 2025Insider tradeSEC
4 · Change in ownershipJun 6, 2025Insider tradeSEC
4 · Change in ownershipJun 4, 2025Insider tradeSEC
4 · Change in ownershipJun 4, 2025Insider tradeSEC
4 · Change in ownershipJun 4, 2025Insider tradeSEC
4 · Change in ownershipJun 4, 2025Insider tradeSEC
4 · Change in ownershipJun 4, 2025Insider tradeSEC
4 · Change in ownershipJun 4, 2025Insider tradeSEC
4 · Change in ownershipJun 4, 2025Insider tradeSEC
4 · Change in ownershipJun 4, 2025Insider tradeSEC
4 · Change in ownershipJun 4, 2025Insider tradeSEC
144 · Notice of proposed saleJun 2, 2025Other filingsSEC
8-K · Current reportJun 2, 2025Current reportSEC
4 · Change in ownershipMay 5, 2025Insider tradeSEC
144 · Notice of proposed saleMay 5, 2025Other filingsSEC
8-K · Current reportApr 24, 2025ResultsSEC
10-Q · Quarterly reportApr 24, 2025Quarterly reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedApr 23, 2025Big-stake noticeSEC
8-K · Current reportApr 22, 2025Current reportSEC
DEFA14A · Additional proxy materialApr 21, 2025Meeting noticeSEC
DEF 14A · Proxy statementApr 21, 2025Meeting noticeSEC
SCHEDULE 13G · Big-stake noticeApr 1, 2025Big-stake noticeSEC
4 · Change in ownershipMar 6, 2025Insider tradeSEC
4 · Change in ownershipMar 6, 2025Insider tradeSEC
4 · Change in ownershipMar 6, 2025Insider tradeSEC
4 · Change in ownershipMar 6, 2025Insider tradeSEC
4 · Change in ownershipMar 6, 2025Insider tradeSEC
4 · Change in ownershipMar 6, 2025Insider tradeSEC
4 · Change in ownershipMar 6, 2025Insider tradeSEC
4 · Change in ownershipMar 6, 2025Insider tradeSEC
4 · Change in ownershipMar 4, 2025Insider tradeSEC
4 · Change in ownershipMar 4, 2025Insider tradeSEC
4 · Change in ownershipMar 4, 2025Insider tradeSEC
4 · Change in ownershipMar 4, 2025Insider tradeSEC
4/A · Change in ownership, amendedMar 3, 2025Insider tradeSEC
4/A · Change in ownership, amendedMar 3, 2025Insider tradeSEC
4/A · Change in ownership, amendedMar 3, 2025Insider tradeSEC
4/A · Change in ownership, amendedMar 3, 2025Insider tradeSEC
4/A · Change in ownership, amendedMar 3, 2025Insider tradeSEC
4/A · Change in ownership, amendedMar 3, 2025Insider tradeSEC
144 · Notice of proposed saleMar 3, 2025Other filingsSEC
144 · Notice of proposed saleMar 3, 2025Other filingsSEC
144 · Notice of proposed saleMar 3, 2025Other filingsSEC
144 · Notice of proposed saleMar 3, 2025Other filingsSEC
144 · Notice of proposed saleMar 3, 2025Other filingsSEC
4 · Change in ownershipMar 3, 2025Insider tradeSEC
4 · Change in ownershipMar 3, 2025Insider tradeSEC
4 · Change in ownershipMar 3, 2025Insider tradeSEC
4 · Change in ownershipMar 3, 2025Insider tradeSEC
4 · Change in ownershipMar 3, 2025Insider tradeSEC
4 · Change in ownershipMar 3, 2025Insider tradeSEC
144 · Notice of proposed saleFeb 28, 2025Other filingsSEC
144 · Notice of proposed saleFeb 28, 2025Other filingsSEC
144 · Notice of proposed saleFeb 28, 2025Other filingsSEC
144 · Notice of proposed saleFeb 28, 2025Other filingsSEC
144 · Notice of proposed saleFeb 28, 2025Other filingsSEC
144 · Notice of proposed saleFeb 27, 2025Other filingsSEC
144 · Notice of proposed saleFeb 27, 2025Other filingsSEC
144 · Notice of proposed saleFeb 27, 2025Other filingsSEC
144 · Notice of proposed saleFeb 27, 2025Other filingsSEC
S-8 · Registration statement for employee plansFeb 27, 2025Offer documentSEC
8-K · Current reportFeb 27, 2025ResultsSEC
10-K · Annual reportFeb 27, 2025Annual reportSEC
4 · Change in ownershipJan 15, 2025Insider tradeSEC
144 · Notice of proposed saleJan 13, 2025Other filingsSEC
8-K · Current reportJan 13, 2025ResultsSEC
3 · Initial statement of ownershipJan 6, 2025Insider tradeSEC
4 · Change in ownershipJan 3, 2025Insider tradeSEC
4 · Change in ownershipJan 3, 2025Insider tradeSEC
4 · Change in ownershipJan 3, 2025Insider tradeSEC
144 · Notice of proposed saleJan 2, 2025Other filingsSEC
8-K/A · Current report, amendedDec 16, 2024Management or board changeSEC
8-K · Current reportDec 2, 2024Current reportSEC

This page holds 200 of 1,000 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from NovoCure Limited’s releases

Common shares
116,445,840
Fully diluted
116,445,840

Fully diluted

LineShares
Common shares116,445,840

Share count over time

CountShares
Nov 22, 2026116,445,840

Open Cap table

Shareholders

Funds

HolderSharesValueAs of
Fidelity Growth Company Fund5.88MUS$100MMay 31, 2026
Vanguard Total Stock Market Index Fund3.49MUS$52.9MJun 30, 2026
iShares Russell 2000 ETF2.78MUS$42.2MJun 30, 2026
Vanguard Small-Cap Index Fund2.52MUS$38.2MJun 30, 2026
Fidelity Growth Company K6 Fund1.73MUS$29.6MMay 31, 2026
Fidelity Series Growth Company Fund1.55MUS$26.4MMay 31, 2026
Vanguard Small-Cap Growth Index Fund1.45MUS$21.9MJun 30, 2026
Vanguard Extended Market Index Fund1.21MUS$18.3MJun 30, 2026
Fidelity Small Cap Index Fund1.17MUS$17.4MJul 31, 2026
iShares Russell 2000 Growth ETF918KUS$13.9MJun 30, 2026
Show 50 holders
HolderSharesValueAs of
iShares Biotechnology ETF735KUS$11.1MJun 30, 2026
Nuveen Quant Small Cap Equity Fund617KUS$9.16MJul 31, 2026
BlackRock Health Sciences Opportunities Portfolio574KUS$9.79MMay 29, 2026
BlackRock Advantage Small Cap Core Fund541KUS$9.22MMay 29, 2026
Fidelity Extended Market Index Fund528KUS$9MMay 31, 2026
Vanguard Russell 2000 Index Fund522KUS$8.89MMay 31, 2026
iShares U.S. Medical Devices ETF494KUS$7.48MJun 30, 2026
Schwab U.S. Small-Cap ETF492KUS$8.38MMay 31, 2026
Vanguard Strategic Equity Fund435KUS$6.6MJun 30, 2026
Vanguard Explorer Fund410KUS$6.09MJul 31, 2026
Vanguard Health Care Index Fund319KUS$5.43MMay 31, 2026
Dimensional U.S. Small Cap ETF288KUS$4.27MJul 31, 2026
Schwab Small-Cap Index Fund260KUS$3.86MJul 31, 2026
Vanguard Strategic Small-Cap Equity Fund258KUS$3.9MJun 30, 2026
U.S. Micro Cap Portfolio255KUS$3.78MJul 31, 2026
First Trust Small Cap Growth AlphaDEX Fund232KUS$3.44MJul 31, 2026
U.S. Small Cap Portfolio224KUS$3.33MJul 31, 2026
LVIP Franklin Templeton Multi-Factor SMID Cap Equity Fund214KUS$3.24MJun 30, 2026
Master Small Cap Index Series200KUS$3.03MJun 30, 2026
Fidelity Total Market Index Fund192KUS$3.26MMay 31, 2026
North Square Dynamic Small Cap Fund164KUS$2.8MMay 31, 2026
Fidelity Series Total Market Index Fund155KUS$2.64MMay 31, 2026
State Street(R) SPDR(R) S&P(R) Health Care Equipment ETF149KUS$2.25MJun 30, 2026
Nuveen Small Cap Blend Index Fund141KUS$2.1MJul 31, 2026
iShares Core S&P Total U.S. Stock Market ETF135KUS$2.04MJun 30, 2026
Strategic Advisers U.S. Total Stock Fund127KUS$2.16MMay 31, 2026
EQ/2000 Managed Volatility Portfolio116KUS$1.76MJun 30, 2026
iShares ESG Aware MSCI USA Small-Cap ETF103KUS$1.75MMay 31, 2026
Nuveen ESG Small-Cap ETF99,493US$1.48MJul 31, 2026
Nuveen Quant Small/Mid Cap Equity Fund97,700US$1.45MJul 31, 2026
Invesco Dorsey Wright Healthcare Momentum ETF97,583US$1.45MJul 31, 2026
Vanguard Russell 2000 Growth Index Fund95,302US$1.62MMay 31, 2026
Nuveen Equity Index Fund93,214US$1.38MJul 31, 2026
Fidelity Small Cap Growth Index Fund93,195US$1.41MJun 30, 2026
Vanguard Total World Stock Index Fund91,130US$1.35MJul 31, 2026
Avantis U.S. Small Cap Value Fund88,397US$1.51MMay 31, 2026
Small Cap Equity Fund88,332US$1.34MJun 30, 2026
Invesco RAFI US 1500 Small-Mid ETF84,656US$1.26MJul 31, 2026
College Retirement Equities Fund - Total Global Stock Account79,100US$1.2MJun 30, 2026
Amplify BlueStar Israel Technology ETF77,252US$1.17MJun 30, 2026

This page holds 50 of 212 holders. Open Shareholders

Insider trades

TradeTradeSharesPriceValueDate
Paravasthu Mukund
Officer: Chief Operating Officer
Sale3,079USD 12.86US$39,602Nov 9, 2026
Brackmann Christoph
Officer: Chief Financial Officer
Sale7,343USD 12.86US$94,446Nov 9, 2026
Puri Michal Nath
Officer: Chief Human Resources Officer
Sale660USD 13.24US$8,738Nov 2, 2026
Leonard Frank X
Officer: Chief Executive Officer
Sale34,273USD 17.93US$615KJun 4, 2026
Hilleman Jeryl L
Director
Sale2,945USD 15.77US$46,443Jun 2, 2026
Leung Gabriel
Director
Sale2,945USD 15.77US$46,443Jun 2, 2026
Hung David
Director
Sale2,945USD 15.77US$46,443Jun 2, 2026
Vernon W Anthony
Director
Sale2,945USD 15.77US$46,443Jun 2, 2026
Scannell Timothy J
Director
Sale2,945USD 15.77US$46,443Jun 2, 2026
Ocean Allyson J
Director
Sale2,945USD 15.77US$46,443Jun 2, 2026
All 11 trades
TradeTradeSharesPriceValueDate
Stafford Kristin
Director
Sale2,945USD 15.77US$46,443Jun 2, 2026

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Louis J Lavigne Jr
Other companies: Alector, Inc. (Director · Since at least Feb 6, 2019); DocuSign, Inc. (Director · Apr 26, 2018 – Jun 17, 2019 · Past); Zynga Inc (Director · Apr 23, 2015 – May 23, 2022 · Past); Depomed Inc (Director · Jul 6, 2013 – May 8, 2018 · Past); Accuray Incorporated (Director · Sep 4, 2009 – Nov 30, 2020 · Past); BMC Software Inc (Director · Aug 22, 2006 – Sep 10, 2013 · Past); Kyphon Inc (Director · Jul 31, 2006 – Nov 2, 2007 · Past); Arena Pharmaceuticals Inc (Director · Jul 28, 2006 – Jul 28, 2006 · Past); Equinix, Inc. (Director · Jun 8, 2006 – Jun 8, 2006 · Past)
Director · Oct 1, 2015 – May 31, 2017 · Past
Robert J Mylod Jr
Other companies: Bending Spoons S.p.A. (Director · Since at least Jul 1, 2026); Vroom, Inc. (Director · Since at least Jun 8, 2020); Booking Holdings Inc. Common Stock (Director · Since at least Feb 28, 2006); Dropbox, Inc. (Director · Mar 22, 2018 – May 20, 2021 · Past); Redfin Corp (Director · Jul 27, 2017 – Jun 12, 2022 · Past); Autoweb Inc (Director · Oct 1, 2015 – Jun 20, 2016 · Past)
Director · Oct 1, 2015 – May 4, 2016 · Past
Jeryl Jeri Hilleman
Other companies: Omada Health, Inc. (Director · Since at least Jun 5, 2025); SI-BONE, Inc. (Director · Since at least Jun 13, 2022); Hillevax Inc (Director · Since at least Apr 28, 2022); Cutera Inc (Director · Jul 12, 2024 – Oct 24, 2024 · Past); Minerva Neurosciences, Inc (Director · Jun 10, 2022 – Sep 27, 2023 · Past)
Director · Since at least Jun 8, 2022
Sherilyn McCoy
Other companies: Kimberly-Clark Corporation (Director · Since at least Sep 12, 2018); Stryker Corporation (Lead Independent Director · Since at least May 2, 2018); Certara, Inc. (Director · Dec 11, 2020 – May 18, 2021 · Past); Avon Products Inc (CEO, Director · Apr 23, 2012 – Apr 23, 2017 · Past); Johnson & Johnson (Member, Executive Committee · Jan 2, 2008 – Feb 9, 2012 · Past)
Director · May 31, 2018 – Jun 9, 2021 · Past
Gabriel Leung
Other companies: Pernix Therapeutics Holdings Inc (Director · Nov 21, 2016 – May 22, 2018 · Past); Delcath Systems, Inc. (Director · Mar 30, 2011 – Jul 7, 2014 · Past); Albany Molecular Research Inc (Director · Nov 2, 2010 – Mar 2, 2015 · Past); Osi Pharmaceuticals Inc (EVP & Pres. Pharma. Business · Jun 13, 2006 – Jun 7, 2010 · Past)
Director · Since at least Oct 1, 2015
W. Anthony Vernon
Other companies: Nuvation Bio Inc. (Director · Since at least Feb 10, 2021); McCormick & Company, Incorporated (Director · Since at least Mar 15, 2018); Intersect ENT Inc (Director · Jun 5, 2018 – Jun 4, 2020 · Past)
Director · Since at least May 31, 2017
Kristin Stafford
Other companies: Theravance Biopharma, Inc. (Chief Financial Officer · Since at least Nov 4, 2026); Zymeworks Inc. (Chief Financial Officer · Since at least Apr 1, 2026)
Director · Since at least Mar 28, 2023
Timothy J Scannell
Other companies: Insulet Corporation (Director · Since at least May 20, 2026); Masimo Corporation (Director · Since at least Apr 29, 2026)
Director · Since at least Jun 2, 2026
David Hung
Other companies: Nuvation Bio Inc. (PRESIDENT AND CEO, Director · Since at least Apr 4, 2025)
Director · Since at least Jun 3, 2025
Ely Benaim
Other companies: Opus Genetics, Inc. (Chief Medical Officer · Feb 2, 2015 – Feb 28, 2019 · Past)
Chief Medical Officer · Jul 24, 2019 – Jan 6, 2023 · Past
All 33 people
PersonSeat
Martin J. Madden
Other companies: Microbot Medical Inc. (Director · Since at least Oct 23, 2019)
Director · Since at least May 21, 2019
Wilhelmus Cm Groenhuysen
Other companies: OptiNose (Director · Oct 12, 2017 – May 21, 2025 · Past)
Chief Operating Officer · Oct 1, 2015 – Jun 28, 2024 · Past
William Doyle
Other companies: ProKidney Corp. (Lead Independent Director · Since at least Nov 19, 2026)
Executive Chairman · Since at least Dec 22, 2025
Allyson J. OceanDirector · Since at least Feb 22, 2023
Arye Barak BenGeneral Counsel · Since at least Apr 14, 2022
Asaf DanzigerDirector · Since at least Oct 1, 2015
Ashley CordovaFormer Chief Executive Officer · Since at least Sep 1, 2020
Charles G Phillips IIIDirector · Oct 1, 2015 – Dec 2, 2019 · Past
Christoph BrackmannChief Financial Officer · Since at least Jan 1, 2025
Eilon D KirsonChief Science Officer · Oct 1, 2015 – Feb 27, 2019 · Past
Frank LeonardChief Executive Officer · Since at least Sep 1, 2020
Kinyip Gabriel LeungDirector · Since at least Nov 5, 2026
Michael J AmbrogiChief Operating Officer · Oct 1, 2015 – Jul 21, 2020 · Past
Michael PuriChief Human Resources Officer · Since at least Nov 5, 2026
Michal Nath PuriChief Human Resources Officer · Since at least Oct 25, 2023
Mukund ParavasthuChief Operating Officer · Since at least Oct 1, 2024
Nicolas LeupinFormer Chief Medical Officer · Since at least Jan 2, 2024
Pritesh ShahChief Growth Officer · Jul 1, 2018 – Nov 7, 2023 · Past
Timothy J LanglossDirector · Oct 1, 2015 – May 5, 2016 · Past
Uri WeinbergChief Medical & Innovation Officer · Since at least Apr 30, 2020
William A. VernonDirector · Since at least Feb 26, 2026
William Patrick BurkeChief Human Resources Officer · Sep 1, 2021 – Jun 30, 2023 · Past
Yoram PaltiChief Technology Officer, Director · Apr 18, 2016 – Aug 28, 2018 · Past

Open People

Log in to ask 6ix AI your own questions about NovoCure Limited.